Three pharmaceutical firms to benefit from strategic alliances with Pfizer Korea

Published: 2004-03-19 06:57:00

Updated: 2004-03-19 06:57:00

Pharmaceutical business sources said that Pfizer Korea has established strategic alliances with three domestic pharmaceutical makers Dongshin Pharm, Ildong Pharm, and Jeil Pharm for marketing of Pfizer Korea's 15 drugs to effectively minimize outlays for overall distribution and promotion of dr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK